Back to News
Market Impact: 0.2
Shuttle Pharmaceuticals Holdings, Inc. Dismisses Forvis Mazars, LLP
Source: Nasdaq
Management & Governance
On October 16, 2026, Shuttle Pharmaceuticals Holdings’ Audit Committee and full Board approved dismissing Forvis Mazars, LLP as the company’s independent registered public accounting firm. The article text is truncated before stating when the dismissal becomes effective or giving a reason.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.15
Ticker Sentiment
SHPH-0.35
More News
- With earnings in rearview mirror, SpaceX-Tesla merger chatter takes center stage
- ‘It wasn’t me, and I don’t think it was Elon’: Trump and his cabinet send mixed messages about what led to Ukraine’s Starshield interruptions
- Mark Zuckerberg owns 13% of Meta but controls 61% of its votes. California’s wealth tax would bill him on the 13%
- Volvo Cars posts Q3 loss of 3.7 billion crowns, to cut 2,500 jobs
- Expion Energy amends private placement terms, updates convertible debenture agreement
- Innventure receives Nasdaq notice for minimum bid price non-compliance
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- AI Research Systems for Hedge Funds: A Pilot Design
- Weekly Update: New Reporting Features, UI Improvements, and Chat Optimizations